Key role for Manchester in beating hospital bugs
Manchester is set to play an important part in a major NHS project to develop and test new infection-beating products in hospitals, and then provide support to roll them out across the NHS.
Central Manchester and Manchester Children’s University Hospitals NHS Trust is one of seven Showcase Hospitals across England participating in the Healthcare Associated Infections (HCAIs) Technology Innovation Programme. The aim is to help further reduce levels of infection, especially MRSA and C. difficile, through the use of new products and technologies.
The Showcase Hospitals will provide facilities in which frontline NHS staff can put new products and equipment designed to combat bugs like MRSA into practice. Evidence of how effective each product or technology is will be collected, along with the views of staff on how easy they are to use, and this information will be shared among hospitals around the country. The NHS Purchasing and Supply Agency (PASA) will then work with the Showcase Hospitals to make successful products more widely available.
“This is a landmark project, and we are very pleased that the Central Manchester and Manchester Children’s University Hospitals NHS Trust has been chosen as one of the seven pioneering sites,” says Gill Heaton, Director of Patient Services/Chief Nurse. Mrs Heaton is managing the project in her role as Director of Infection Prevention for the Trust.
“Developing an infection in hospital is a worry for many patients, and infection control is a top priority for the six hospitals in our Trust. We've worked very hard over the past year to significantly reduce infections. As a result, we are one of the best performing trusts in the North West, and this expertise in infection control has been reinforced by our selection as a Showcase Hospital."